Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
Kyndryl Shares Rally Amid Internal Review and Outlook Reset
Kyndryl Holdings saw its shares climb approximately 9% in after-hours trading, extending a recovery from a sharp decline earlier in the week. The IT services provider is navigating a delayed quarterly filing and an internal audit committee review of its financial controls.
Lockheed Martin Shares Hold Steady Amid Pentagon Contractor Review
Lockheed Martin shares traded near $630 as the Pentagon initiates an extended review of major defense contractors, potentially impacting shareholder returns. CEO and CFO are scheduled to speak at a Citi conference next week.
Hims & Hers Shares Stabilize After Novo Nordisk Patent Lawsuit Rattles Weight-Loss Strategy
Hims & Hers stock edged up 0.1% premarket following steep declines after Novo Nordisk filed a patent lawsuit over compounded semaglutide. Investors await court developments, FDA signals, and the company's Feb. 23 earnings.
IRS Warns 2026 Tax Refund Delays Likely Without Accurate Direct Deposit Details
The IRS cautions that missing or incorrect bank information will hold 2026 refunds, with updates only accepted by mail. Most e-filed refunds arrive within 21 days, but delays could extend into March.
Tax Season 2026: Key Deadlines, Refund Timelines, and Penalty Warnings
The IRS sets April 15, 2026 as the federal filing deadline for 2025 returns, with extensions available until October. Most refunds arrive within 21 days, but some credits may delay payments until March.
GSK's RSV Vaccine Advances in Chinese Regulatory Review, Eyes 2027 Decision
GSK's Arexvy RSV vaccine application has been accepted for review by China's drug regulator, with a potential approval decision expected in 2027. The stock edged higher as JPMorgan raised its price target and the company's dividend ex-date approaches.
Meta Shares Dip Amid Regulatory Pressure in Germany and India
Meta Platforms stock declined roughly 1% in after-hours trading following a German court ruling ordering a €30 million payment to Deutsche Telekom and India's new three-hour content removal mandate.
Hims & Hers Shares Extend Decline Amid Novo Nordisk Patent Lawsuit Over Compounded Weight-Loss Drugs
Hims & Hers Health stock fell another 5.6% as Novo Nordisk filed a patent lawsuit seeking to block compounded versions of Wegovy, tightening regulatory pressure on the online health provider's GLP-1 offerings.
JPMorgan Faces Internal Pushback Over Full-Time Office Mandate
JPMorgan Chase employees warn that resisting CEO Jamie Dimon's five-day office requirement could harm careers, as a petition for hybrid work gains limited traction.
Meta Faces EU Pressure Over WhatsApp AI Access, Stock Dips Slightly
Meta shares edged lower as EU regulators consider forcing WhatsApp to open its business platform to rival AI assistants. Separately, WhatsApp won a court ruling to challenge a €225 million privacy fine.
Hims & Hers Stock Extends Slide Amid Weight-Loss Pill Halt, Regulatory Pressure
Hims & Hers Health shares fell another 4.2% premarket Tuesday, compounding a 16% drop Monday, after discontinuing its compounded semaglutide pill. The company faces a patent lawsuit from Novo Nordisk and potential FDA action.